Related Experiment Videos
Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting
Y J Gu1, M A Mariani, W van Oeveren
1Department of Cardiothoracic Surgery, Thorax Center, University Hospital, Groningen, The Netherlands.
Insights
Minimally invasive coronary artery bypass grafting significantly reduces the inflammatory response and postoperative complications compared to conventional surgery. This approach leads to better patient outcomes and shorter hospital stays.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Procedures
- Inflammatory Response
Background:
- Inflammation-associated morbidity and subclinical inflammatory markers are concerns in coronary artery bypass grafting (CABG).
- Minimally invasive CABG without cardiopulmonary bypass (CPB) is being explored as an alternative to conventional CABG with CPB.
Purpose of the Study:
- To evaluate the impact of minimally invasive CABG without CPB on clinical morbidity.
- To assess subclinical markers of the inflammatory response in patients undergoing minimally invasive CABG compared to conventional CABG.
Main Methods:
- A prospective study randomized 62 patients with isolated left anterior descending coronary artery stenosis into two groups: minimally invasive CABG (n=31) and conventional CABG with CPB (n=31).
- Subclinical inflammatory markers (leukocyte elastase, platelet beta-thromboglobulin, complement C3a) were measured in a subgroup of 10 patients per group.
Main Results:
- Minimally invasive CABG showed no significant increase in inflammatory markers, unlike conventional CABG where markers increased significantly.
- Patients undergoing minimally invasive CABG experienced shorter operation times, reduced blood loss, less ventilatory support, and shorter hospital stays.
- Key metrics for minimally invasive CABG: operation duration (104 min), blood loss (312 mL), ventilatory support (7.7 hrs), hospital stay (4.4 days).
Conclusions:
- Minimally invasive coronary artery bypass grafting without cardiopulmonary bypass significantly reduces the systemic inflammatory response.
- This approach is associated with decreased postoperative morbidity and shorter hospital stays compared to conventional CABG with cardiopulmonary bypass.
- Minimally invasive CABG offers a potentially superior alternative for selected patients requiring coronary artery bypass surgery.
Background:
The aim of this prospective study was to determine whether the inflammation-associated clinical morbidity as well as the subclinical markers of the inflammatory response are reduced in patients who undergo minimally invasive coronary artery bypass grafting without cardiopulmonary bypass.
Methods:
From June 1995 to June 1996, 62 consecutive patients with isolated stenosis of the left anterior descending coronary artery were assigned randomly to two groups: 31 patients underwent minimally invasive coronary artery bypass grafting and 31 patients underwent conventional coronary artery bypass grafting with cardiopulmonary bypass. In a subgroup of 10 patients in each group, subclinical markers were measured to determine the level of the inflammatory response generated during the operation.
Results:
In the group that underwent minimally invasive coronary artery bypass grafting, leukocyte elastase, platelet beta-thromboglobulin, and complement C3a were unchanged at the end of the procedure compared with their baseline concentrations, whereas these inflammatory markers were increased significantly in the group that underwent conventional coronary artery bypass grafting with cardiopulmonary bypass. The patients who underwent minimally invasive coronary artery bypass grafting had a shorter duration of operation (104 +/- 28 versus 140 +/- 28 minutes; p < 0.01), less blood loss (312 +/- 167 versus 788 +/- 365 mL; p < 0.01), shorter ventilatory support (7.7 +/- 4.1 versus 12.9 +/- 3.4 hours; p < 0.01), and a shorter postoperative hospital stay (4.4 +/- 1.7 versus 7.7 +/- 2.6 days; p < 0.01) than the patients who underwent the conventional procedure.
Conclusions:
These data suggest that patients who undergo minimally invasive coronary artery bypass grafting have a significant reduction in the systemic inflammatory response, postoperative morbidity, and hospital stay compared with patients who undergo conventional coronary artery bypass grafting with cardiopulmonary bypass.